🚀 Welcome to our new website!
We’ve completely redesigned it to offer you a smoother, more intuitive and more enjoyable experience with enriched content. Explore what’s new and let us guide you! ✨
Support our Foundation of Myology project
INSTITUTE OF MYOLOGY
Research
Eline Lemerle, a postdoctoral research fellow in the Muscle cell organisation and therapy for dominant centronuclear myopathy team headed by Marc Bitoun et Stéphane Vassilopoulos,…
Research
Researchers from the Repeat Expansions & Myotonic Dystrophy (REDs) team in the Center of Research in Myology at the Institute, whose work focuses on type…
Research
Julia Pereira Lemos, a researcher in the Biotherapy for motor neuron diseases (ALS & SMA) team in the Center for Research in Myology at the…
Research
The anti-CD19 CAR-T cells KYV-101 are being evaluated in a Phase II/III trial involving 66 patients with refractory generalised autoimmune myasthenia gravis. Initial results for…
The Institute of Myology brings together 300 experts in muscle and muscle disease who have been dedicated for 30 years to muscle science and medicine, known as myology. Centred on the patient, this international centre of expertise coordinates activities in diagnosis, care, clinical research, evaluation, basic and applied research, and teaching.
Tailored care and long-term follow-up
for patients
Studying muscle and evaluating the efficacy of innovative therapies for patients
Understanding muscle and discovering new therapies for patients
Spreading knowledge about muscle and muscle disease and raising the profile of myology
OUR MISSION
Studying, diagnosing, evaluating and treating muscle and muscle disease, and promoting myology as a cross-cutting discipline for the benefit of as many people as possible.
Did you know?
Our muscles account for
40%
of our body mass
The Institute of Myology has two clinical trial platforms,
I-Motion Pediatric and I-Motion Adults.
I-Motion Pediatric is a clinical trial platform for children with neuromuscular diseases. It runs around 15 trials sponsored by academic or industry laboratories.
I-Motion Adults evaluates new treatments in adults with neuromuscular diseases. Around 40 trials are currently under way there.
600: that is the number of muscles in our body.
Beyond their role in motor function and movement, our muscles interact with many organs and are essential to our overall health.